Presentation TCT 2017 Valve Degeneration and Leaflet Mobility Considerations: Assessing Clinical Relevance Presenter: Lars Sondergaard October 31, 2017 REGISTER for free or LOG IN to view this content Structural Heart Presentation TCT 2017 Aortic Valve Up Next Presentation TCT 2017 FDA Perspectives on TAVR Label Expansion Using Real-World Evidence, Valve Degeneration, and Embolic Protection Devices Presenter: John C Laschinger October 31, 2017 More slides + Presentation TCT 2017 Cath Lab Economics 101: MACRA and MIPS Presenter: Daniel M. Kolansky October 31, 2017 Presentation TCT 2017 CMS Strategy and the Move to Value Presenter: John A. Spertus October 31, 2017 We Recommend
Presentation TCT 2017 FDA Perspectives on TAVR Label Expansion Using Real-World Evidence, Valve Degeneration, and Embolic Protection Devices Presenter: John C Laschinger October 31, 2017
Presentation TCT 2017 Cath Lab Economics 101: MACRA and MIPS Presenter: Daniel M. Kolansky October 31, 2017